{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:28:26Z","timestamp":1787894906321,"version":"build-2784847793"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA016644"],"award-info":[{"award-number":["DA016644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State of Washington Initiative Measure 502"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.drugalcdep.2017.01.046","type":"journal-article","created":{"date-parts":[[2017,4,15]],"date-time":"2017-04-15T02:01:34Z","timestamp":1492221694000},"page":"187-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Cannabidiol-\u0394 9 -tetrahydrocannabinol interactions on acute pain and locomotor activity"],"prefix":"10.1016","volume":"175","author":[{"given":"Stevie C.","family":"Britch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Clowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5055\/jom.2009.0016","article-title":"Medicinal use of cannabis in the united states: historical perspectives, current trends, and future directions","volume":"5","author":"Aggarwal","year":"2008","journal-title":"J. Opioid Manage."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pain.2006.04.001","article-title":"Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist","volume":"124","author":"Amaya","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/kei183","article-title":"Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis","volume":"45","author":"Blake","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2009.06.009","article-title":"Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception","volume":"105","author":"Booker","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0025","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/tx9800598","article-title":"Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator","volume":"11","author":"Bornheim","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0030","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0090-9556(25)06664-4","article-title":"Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain","volume":"23","author":"Bornheim","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2004.04.022","article-title":"The antinociceptive effect of delta 9-tetrahydrocannabinol in the arthritic rat","volume":"493","author":"Cox","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.111.188540","article-title":"Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by \u22069-tetrahydrocannabinol and CP55,940 in the rat","volume":"340","author":"Craft","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nn0208-124","article-title":"Why endocannabinoids are not all alike","volume":"11","author":"Di Marzo","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-011-2566-z","article-title":"Anxiogenic-like effects of chronic cannabidiol administration in rats","volume":"221","author":"El Batsh","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00429130","article-title":"Modification of \u22069-THC actions by cannabinol and cannabidiol in the rat","volume":"38","author":"Fernandes","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0953-816X.2004.03177.x","article-title":"Effects of coadministration of cannabinoids and morphine on nociceptive behaviour: brain monoamines and HPA axis activity in a rat model of persistent pain","volume":"19","author":"Finn","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0065","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(77)90178-3","article-title":"\u22069-THC and 11-OH-\u22069-THC: behavioral effects and relationship to plasma and brain levels","volume":"20","author":"Ford","year":"1977","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0070","series-title":"The Neuroendocrine Control of the Rat Estrous Cycle","author":"Freeman","year":"1994"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0376-8716(99)00128-3","article-title":"Antinociceptive, subjective and behavioral effects of smoked marijuana in humans","volume":"59","author":"Greenwald","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0080","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/npp.2015.367","article-title":"Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis","volume":"41","author":"Haney","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbr.2012.02.048","article-title":"Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety","volume":"231","author":"Harte-Hargrove","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainres.2007.09.090","article-title":"Cannabidiol potentiates pharmacological effects of \u22069-tetrahydrocannabinol via CB1 receptor-dependent mechanism","volume":"1188","author":"Hayakawa","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K","article-title":"Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study","volume":"37","author":"Hohmann","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0100","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bcp.2005.12.033","article-title":"The effects of cannabinoids on p-glycoprotein transport and expression in multidrug resistant cells","volume":"71","author":"Holland","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0105","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","article-title":"The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids","volume":"152","author":"Holland","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0110","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00498259609046707","article-title":"Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes","volume":"26","author":"Jaeger","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00428793","article-title":"Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol","volume":"33","author":"Karniol","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-011-2342-0","article-title":"Cannabidiol potentiates \u22069-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats","volume":"218","author":"Klein","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0135","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11481-015-9600-6","article-title":"Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials","volume":"10","author":"Lynch","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nn2042","article-title":"Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum","volume":"11","author":"Maccarrone","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(99)00998-2","article-title":"Two distinctive antinociceptive systems in rats with pathological pain","volume":"280","author":"Mao","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1535-7163.MCT-09-0407","article-title":"Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival","volume":"9","author":"Marcu","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mcn.2008.09.001","article-title":"TRPV1 channels facilitate glutamate transmission in the striatum","volume":"40","author":"Musella","year":"2009","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.ftd.0000177223.19294.5c","article-title":"Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of \u22069-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract","volume":"27","author":"Nadulski","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0170","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0006-2952(91)90657-Q","article-title":"Sex difference in the oxidative metabolism of \u22069-tetrahydrocannabinol in the rat","volume":"41","author":"Narimatsu","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","article-title":"Effect of \u2206-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults","volume":"24","author":"Nicholson","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0180","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/BF01922823","article-title":"A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol","volume":"29","author":"Perez-Reyes","year":"1973","journal-title":"Experientia"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0185","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0006-2952(01)00616-5","article-title":"Cannabinoid-induced alterations in brain disposition of drugs of abuse","volume":"61","author":"Reid","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0190","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.clinthera.2007.09.013","article-title":"Oromucosal \u22069-tetrahydrocannabinol\/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial","volume":"29","author":"Rog","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-3806(02)00306-1","article-title":"Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats","volume":"136","author":"Romero","year":"2002","journal-title":"Brain. Res Dev. Brain Res."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00432273","article-title":"Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse","volume":"61","author":"Sanders","year":"1979","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0205","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1185\/030079906X112651","article-title":"Delta\u20109-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief","volume":"22","author":"Schley","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuroscience.2010.04.007","article-title":"Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats","volume":"168","author":"Sciolino","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0091-3057(97)00583-2","article-title":"Characterization of \u22069-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats","volume":"60","author":"Smith","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00421466","article-title":"Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats","volume":"40","author":"Sofia","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0225","doi-asserted-by":"crossref","first-page":"e35937","DOI":"10.1371\/journal.pone.0035937","article-title":"Enhanced brain disposition and effects of \u22069-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice","volume":"7","author":"Spiro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/bph.13333","article-title":"Neural correlates of interactions between cannabidiol and \u22069-tetrahydrocannabinol in mice: implications for medical cannabis","volume":"173","author":"Todd","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(01)01267-5","article-title":"Sex differences in antinociceptive and motoric effects of cannabinoids","volume":"430","author":"Tseng","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2004.01.029","article-title":"Pharmacokinetic factors in sex differences in \u22069-tetrahydrocannabinol-induced behavioral effects in rats","volume":"154","author":"Tseng","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0245","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.104.080739","article-title":"\u22069-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice","volume":"314","author":"Varvel","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0250","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00213-006-0356-9","article-title":"Interactions between THC and cannabidiol in mouse models of cannabinoid activity","volume":"186","author":"Varvel","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0255","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0260","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.1983.179","article-title":"Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women","volume":"34","author":"Wall","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0265","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0270","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.lfs.2006.12.032","article-title":"Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes","volume":"80","author":"Watanabe","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2014.05.057","article-title":"Sex differences in \u22069-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats","volume":"576","author":"Wiley","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0280","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/jpet.106.108126","article-title":"Pharmacological effects of acute and repeated administration of \u22069-tetrahydrocannabinol in adolescent and adult rats","volume":"320","author":"Wiley","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0285","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/jpet.105.098541","article-title":"Characterization of p-glycoprotein inhibition by major cannabinoids from marijuana","volume":"317","author":"Zhu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00213-011-2495-x","article-title":"Interaction between cannabidiol (CBD) and \u03949-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids","volume":"219","author":"Zuardi","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.01.046_bib0295","first-page":"12","article-title":"Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats","volume":"269","author":"Zuardi","year":"1984","journal-title":"Arch. Int. Pharmacodyn. Ther."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617301680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617301680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:31:14Z","timestamp":1750199474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617301680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":59,"alternative-id":["S0376871617301680"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.046","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol-\u03949-tetrahydrocannabinol interactions on acute pain and locomotor activity","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}